S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.14 (+3.92%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.60 (+2.11%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.14 (+3.92%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.60 (+2.11%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.14 (+3.92%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.60 (+2.11%)
S&P 500   3,659.04 (-0.09%)
DOW   29,789.71 (-0.11%)
QQQ   303.15 (-0.10%)
AAPL   122.85 (+0.11%)
MSFT   214.17 (-0.94%)
FB   287.96 (+0.49%)
GOOGL   1,824.13 (+1.60%)
AMZN   3,204.57 (-0.48%)
TSLA   560.67 (-4.12%)
NVDA   541.50 (+1.10%)
BABA   261.72 (-0.87%)
CGC   28.43 (+6.68%)
GE   10.35 (+1.97%)
MU   68.49 (+2.10%)
AMD   93.58 (+1.03%)
T   28.94 (+0.24%)
NIO   47.14 (+3.92%)
F   9.18 (-0.65%)
ACB   11.25 (+15.38%)
NFLX   502.66 (-0.38%)
BA   218.96 (+2.79%)
GILD   61.17 (+0.08%)
DIS   152.60 (+2.11%)
Log in
ARCA:MYO

Myomo Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume138,546 shs
Market Capitalization$15.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient's weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.13 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone617 996 9058
Employees49

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.84 million
Book Value$3.18 per share

Profitability

Net Income$-10,710,000.00
Net Margins-316.37%

Miscellaneous

Market Cap$15.94 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive MYO News and Ratings via Email

Sign-up to receive the latest news and ratings for MYO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Myomo (ARCA:MYO) Frequently Asked Questions

What stocks does MarketBeat like better than Myomo?

Wall Street analysts have given Myomo a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Myomo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Myomo's key competitors?

Who are Myomo's key executives?

Myomo's management team includes the following people:
  • Mr. Paul R. Gudonis, Chairman, Pres & CEO (Age 65, Pay $310.26k)
  • Mr. David A. Henry, Chief Financial Officer (Age 59, Pay $274.18k)
  • Mr. Jonathan Naft, VP & GM (Age 55, Pay $260.39k)
  • Mr. Clifford J. Conneighton, Chief Marketing Officer (Age 70)
  • Dr. Brandon Green DO, BOCP, Chief Medical Officer (Age 37)
  • Mr. Micah J. Mitchell, Chief Commercial Officer (Age 44)

What is Myomo's stock symbol?

Myomo trades on the ARCA under the ticker symbol "MYO."

How do I buy shares of Myomo?

Shares of MYO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Myomo?

Myomo has a market capitalization of $0.00 and generates $3.84 million in revenue each year. The company earns $-10,710,000.00 in net income (profit) each year or ($19.35) on an earnings per share basis. Myomo employs 49 workers across the globe.

What is Myomo's official website?

The official website for Myomo is www.myomo.com.

How can I contact Myomo?

Myomo's mailing address is One Broadway 14th Floor, Cambridge MA, 02142. The company can be reached via phone at 617 996 9058 or via email at [email protected]

This page was last updated on 12/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.